Article Information
History
- October 2, 2019.
Article Versions
- You are currently viewing Version 1 of this article (October 2, 2019 - 13:44).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mee Jung Ko1,3,4,
- Terrance Chiang1,
- Arbaaz M. Mukadam1,
- Grace E. Mulia1,
- Anna M. Gutridge1,3,
- Julia A. Chester2,3,4 and
- Richard M. van Rijn1,3,4,5,‡,*
- 1Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, 47907, USA
- 2Department of Psychological Sciences, College of Health and Human Sciences, Purdue University, West Lafayette, IN, 47907, USA
- 3Purdue Institute for Integrative Neuroscience, West Lafayette, IN, 47907, USA
- 4Purdue Interdisciplinary Life Sciences Graduate Program, West Lafayette, IN, 47907, USA
- 5Purdue Institute for Drug Discovery, West Lafayette, IN, 47907, USA
- ↵*Correspondence: rvanrijn{at}purdue.edu
Posted October 02, 2019.
β-arrestin-dependent ERK signaling positively correlates with reduced anxiety-like and conditioned fear-related behavior in mice
